References
Abbadie C, Pasternak GW (2001) Differential in vivo internalization of MOR-1 and MOR-1C by morphine. Neuroreport 12:3069–3072
Bolan EA, Tallarida RJ, Pasternak GW (2002) Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes. J Pharmacol Exp Ther 303:557–562
Caraceni A, Portenoy RK (1999) An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 82:263–274
Cherny NI (2005) How to deal with difficult pain problems. Ann Oncol 16(Suppl 2):ii79–ii87
Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V, Expert Working Group of the European Association of Palliative Care Network (2001) Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19:2542–2554
De Lima L, Sweeney C, Palmer JL, Bruera E (2004) Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother 18:59–70
Fainsinger RL, Nekolaichuk CL, Lawlor PG, Neumann CM, Hanson J, Vigano A (2005) A multicenter study of the revised Edmonton staging system for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage 29:224–237
Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA (2004) A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101:5135–5139
Gourlay GK (2001) Treatment of cancer pain with transdermal fentanyl. Lancet Oncol 2:165–172
Grach M, Massalha W, Pud D, Adler R, Eisenberg E (2004) Can coadministration of oxycodone and morphine produce analgesic synergy in humans? An experimental cold pain study. Br J Clin Pharmacol 58:235–242
Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C et al (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84:587–593
Indelicato RA, Portenoy RK (2002) Opioid rotation in the management of refractory cancer pain. J Clin Oncol 20:348–352
Lauretti GR, Oliveira GM, Pereira NL (2003) Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. Br J Cancer 89:2027–2030
Mancini IL, Hanson J, Neumann CM, Bruera ED (2000) Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study. J Palliat Med 3:49–56
Mercadante S, Villari P, Ferrera P, Casuccio A (2004) Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer 12:762–766
Miaskowski C, Dodd M, West C, Schumacher K, Paul SM, Tripathy D, Koo P (2004) Randomized clinical trial of the effectiveness of a self-care intervention to improve cancer pain management. J Clin Oncol 22:1713–1720
Morita T, Tei Y, Inoue S (2003) Agitated terminal delirium and association with partial opioid substitution and hydration. J Palliat Med 6:557–563
Nauck F, Ostgathe C, Klaschik E, Bausewein C, Fuchs M, Lindena G, Neuwohner K, Schulenberg D, Radbruch L, Working Group on the Core Documentation for Palliative Care Units in Germany (2004) Drugs in palliative care: results from a representative survey in Germany. Palliat Med 18:100–107
Ross FB, Smith MT (1997) The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain 73:151–157
Strasser F (2003) Pathophysiology of anorexia/cachexia syndrome. In: Doyle D, Hanks G, Cherny N, Sir Calman K (eds). Oxford textbook of palliative medicine, 3rd edn. Oxford University Press, Oxford, pp 520–533
Strasser F, Walker P, Bruera E (2005) Palliative pain management: when both pain and suffering hurt. J Palliat Care 21(2):69–79
Wiffen PJ, Edwards JE, Barden J, McQuay HJ (2003) Oral morphine for cancer pain. Cochrane Database Syst Rev 4:CD003868
http://www.eapcnet.org/researchNetwork/researchprojects.asp#EPOS
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Strasser, F. Promoting science in a pragmatic world: not (yet) time for partial opioid rotation. Support Care Cancer 13, 765–768 (2005). https://doi.org/10.1007/s00520-005-0855-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-005-0855-y